APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Abdominal Aortic Aneurysm Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Abdominal Aortic Aneurysm Drug Market Outlook and Growth Opportunities 2026

Report ID 173959330419 December 2025193 pages

Choose your research edition.

Industry ResearchAbdominal Aortic Aneurysm Drug Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Abdominal Aortic Aneurysm Drug Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Abdominal Aortic Aneurysm Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Abdominal Aortic Aneurysm Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Abdominal Aortic Aneurysm Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Abdominal Aortic Aneurysm Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Abdominal Aortic Aneurysm Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Abdominal Aortic Aneurysm Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Abdominal Aortic Aneurysm Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Abdominal Aortic Aneurysm Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Abdominal Aortic Aneurysm Drug market include Novartis AG, AstraZeneca Plc, Vida Therapeutics Inc. and Carolus Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Abdominal Aortic Aneurysm Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Abdominal Aortic Aneurysm Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Abdominal Aortic Aneurysm Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Abdominal Aortic Aneurysm Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Abdominal Aortic Aneurysm Drug Segment by Company

Novartis AG

AstraZeneca Plc

Vida Therapeutics Inc.

Carolus Therapeutics, Inc.

Abdominal Aortic Aneurysm Drug Segment by Type

BSN-908

Ticagrelor

Canakinumab

CT-2009

Others

Abdominal Aortic Aneurysm Drug Segment by Application

Hospital

Clinic

Others

Abdominal Aortic Aneurysm Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Abdominal Aortic Aneurysm Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Abdominal Aortic Aneurysm Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Abdominal Aortic Aneurysm Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Abdominal Aortic Aneurysm Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Abdominal Aortic Aneurysm Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Abdominal Aortic Aneurysm Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Abdominal Aortic Aneurysm Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Abdominal Aortic Aneurysm Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Abdominal Aortic Aneurysm Drug industry.

Chapter 3: Detailed analysis of Abdominal Aortic Aneurysm Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Abdominal Aortic Aneurysm Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Abdominal Aortic Aneurysm Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Abdominal Aortic Aneurysm Drug Industry Trends Table 2. Abdominal Aortic Aneurysm Drug Industry Drivers Table 3. Abdominal Aortic Aneurysm Drug Industry Opportunities and Challenges Table 4. Abdominal Aortic Aneurysm Drug Industry Restraints Table 5. Global Abdominal Aortic Aneurysm Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Abdominal Aortic Aneurysm Drug Revenue Share by Company (2021-2026) Table 7. Global Abdominal Aortic Aneurysm Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Company (2021-2026) Table 9. Global Abdominal Aortic Aneurysm Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Abdominal Aortic Aneurysm Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Abdominal Aortic Aneurysm Drug Key Company Manufacturing Base & Headquarters Table 12. Global Abdominal Aortic Aneurysm Drug Company, Product Type & Application Table 13. Global Abdominal Aortic Aneurysm Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of BSN-908 Table 18. Significant Companies of Ticagrelor Table 19. Significant Companies of Canakinumab Table 20. Significant Companies of CT-2009 Table 21. Significant Companies of Others Table 22. Global Abdominal Aortic Aneurysm Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Abdominal Aortic Aneurysm Drug Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Abdominal Aortic Aneurysm Drug Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Type (2021-2026) Table 26. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Type (2027-2032) Table 27. Global Abdominal Aortic Aneurysm Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Abdominal Aortic Aneurysm Drug Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Abdominal Aortic Aneurysm Drug Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Type (2021-2026) Table 31. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Abdominal Aortic Aneurysm Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Abdominal Aortic Aneurysm Drug Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Abdominal Aortic Aneurysm Drug Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Application (2021-2026) Table 39. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Application (2027-2032) Table 40. Global Abdominal Aortic Aneurysm Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Abdominal Aortic Aneurysm Drug Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Abdominal Aortic Aneurysm Drug Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Application (2021-2026) Table 44. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Application (2027-2032) Table 45. Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Abdominal Aortic Aneurysm Drug Sales by Region (2021-2026) & (K Units) Table 47. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2021-2026) Table 48. Global Abdominal Aortic Aneurysm Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2027-2032) Table 50. Global Abdominal Aortic Aneurysm Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Abdominal Aortic Aneurysm Drug Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Region (2021-2026) Table 53. Global Abdominal Aortic Aneurysm Drug Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Region (2027-2032) Table 55. Global Abdominal Aortic Aneurysm Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Abdominal Aortic Aneurysm Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Abdominal Aortic Aneurysm Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Abdominal Aortic Aneurysm Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026) & (K Units) Table 60. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2021-2026) Table 61. Global Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032) & (K Units) Table 62. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2027-2032) Table 63. Global Abdominal Aortic Aneurysm Drug Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Abdominal Aortic Aneurysm Drug Sales Value Market Share by Country (2021-2026) Table 65. Global Abdominal Aortic Aneurysm Drug Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Abdominal Aortic Aneurysm Drug Sales Value Market Share by Country (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Abdominal Aortic Aneurysm Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Novartis AG Abdominal Aortic Aneurysm Drug Product Portfolio Table 71. Novartis AG Recent Development Table 72. AstraZeneca Plc Company Information Table 73. AstraZeneca Plc Business Overview Table 74. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product Portfolio Table 76. AstraZeneca Plc Recent Development Table 77. Vida Therapeutics Inc. Company Information Table 78. Vida Therapeutics Inc. Business Overview Table 79. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product Portfolio Table 81. Vida Therapeutics Inc. Recent Development Table 82. Carolus Therapeutics, Inc. Company Information Table 83. Carolus Therapeutics, Inc. Business Overview Table 84. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product Portfolio Table 86. Carolus Therapeutics, Inc. Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Abdominal Aortic Aneurysm Drug Distributors List Table 90. Abdominal Aortic Aneurysm Drug Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Abdominal Aortic Aneurysm Drug Product Image Figure 2. Global Abdominal Aortic Aneurysm Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Abdominal Aortic Aneurysm Drug Sales (2021-2032) & (K Units) Figure 5. Global Abdominal Aortic Aneurysm Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Abdominal Aortic Aneurysm Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. BSN-908 Image Figure 10. Ticagrelor Image Figure 11. Canakinumab Image Figure 12. CT-2009 Image Figure 13. Others Image Figure 14. Global Abdominal Aortic Aneurysm Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Abdominal Aortic Aneurysm Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Type (2021-2032) Figure 17. Global Abdominal Aortic Aneurysm Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Abdominal Aortic Aneurysm Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Abdominal Aortic Aneurysm Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Abdominal Aortic Aneurysm Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Application (2021-2032) Figure 26. Global Abdominal Aortic Aneurysm Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Abdominal Aortic Aneurysm Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Application (2021-2032) Figure 29. Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Abdominal Aortic Aneurysm Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Abdominal Aortic Aneurysm Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 34. North America Abdominal Aortic Aneurysm Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Abdominal Aortic Aneurysm Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 40. South America Abdominal Aortic Aneurysm Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Abdominal Aortic Aneurysm Drug Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Abdominal Aortic Aneurysm Drug Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • BSN-908
  • Ticagrelor
  • Canakinumab
  • CT-2009
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • AstraZeneca Plc
  • Vida Therapeutics Inc.
  • Carolus Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  4. 1.2.2 Global Abdominal Aortic Aneurysm Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Abdominal Aortic Aneurysm Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Abdominal Aortic Aneurysm Drug Market Dynamics
  1. 2.1 Abdominal Aortic Aneurysm Drug Industry Trends
  2. 2.2 Abdominal Aortic Aneurysm Drug Industry Drivers
  3. 2.3 Abdominal Aortic Aneurysm Drug Industry Opportunities and Challenges
  4. 2.4 Abdominal Aortic Aneurysm Drug Industry Restraints
3 Abdominal Aortic Aneurysm Drug Market by Company
  1. 3.1 Global Abdominal Aortic Aneurysm Drug Company Revenue Ranking in 2025
  2. 3.2 Global Abdominal Aortic Aneurysm Drug Revenue by Company (2021-2026)
  3. 3.3 Global Abdominal Aortic Aneurysm Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Abdominal Aortic Aneurysm Drug Average Price by Company (2021-2026)
  5. 3.5 Global Abdominal Aortic Aneurysm Drug Company Ranking (2024-2026)
  6. 3.6 Global Abdominal Aortic Aneurysm Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Abdominal Aortic Aneurysm Drug Company Product Type and Application
  8. 3.8 Global Abdominal Aortic Aneurysm Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Abdominal Aortic Aneurysm Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Abdominal Aortic Aneurysm Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Abdominal Aortic Aneurysm Drug Market by Type
  1. 4.1 Abdominal Aortic Aneurysm Drug Type Introduction
  2. 4.1.1 BSN-908
  3. 4.1.2 Ticagrelor
  4. 4.1.3 Canakinumab
  5. 4.1.4 CT-2009
  6. 4.1.5 Others
  7. 4.2 Global Abdominal Aortic Aneurysm Drug Sales Volume by Type
  8. 4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Abdominal Aortic Aneurysm Drug Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Abdominal Aortic Aneurysm Drug Sales Value by Type
  12. 4.3.1 Global Abdominal Aortic Aneurysm Drug Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Type (2021-2032)
  14. 4.3.3 Global Abdominal Aortic Aneurysm Drug Sales Value Share by Type (2021-2032)
5 Abdominal Aortic Aneurysm Drug Market by Application
  1. 5.1 Abdominal Aortic Aneurysm Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Abdominal Aortic Aneurysm Drug Sales Volume by Application
  6. 5.2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Abdominal Aortic Aneurysm Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Abdominal Aortic Aneurysm Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Abdominal Aortic Aneurysm Drug Sales Value by Application
  10. 5.3.1 Global Abdominal Aortic Aneurysm Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Abdominal Aortic Aneurysm Drug Sales Value Share by Application (2021-2032)
6 Abdominal Aortic Aneurysm Drug Regional Sales and Value Analysis
  1. 6.1 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Abdominal Aortic Aneurysm Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Abdominal Aortic Aneurysm Drug Sales by Region (2027-2032)
  5. 6.3 Global Abdominal Aortic Aneurysm Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Abdominal Aortic Aneurysm Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Abdominal Aortic Aneurysm Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Abdominal Aortic Aneurysm Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  12. 6.6.2 North America Abdominal Aortic Aneurysm Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Abdominal Aortic Aneurysm Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  21. 6.9.2 South America Abdominal Aortic Aneurysm Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Value Share by Country, 2025 VS 2032
7 Abdominal Aortic Aneurysm Drug Country-level Sales and Value Analysis
  1. 7.1 Global Abdominal Aortic Aneurysm Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Abdominal Aortic Aneurysm Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Abdominal Aortic Aneurysm Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Abdominal Aortic Aneurysm Drug Sales by Country (2027-2032)
  6. 7.4 Global Abdominal Aortic Aneurysm Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Abdominal Aortic Aneurysm Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Abdominal Aortic Aneurysm Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Abdominal Aortic Aneurysm Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Abdominal Aortic Aneurysm Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Abdominal Aortic Aneurysm Drug Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 AstraZeneca Plc
  8. 8.2.1 AstraZeneca Plc Company Information
  9. 8.2.2 AstraZeneca Plc Business Overview
  10. 8.2.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product Portfolio
  12. 8.2.5 AstraZeneca Plc Recent Developments
  13. 8.3 Vida Therapeutics Inc.
  14. 8.3.1 Vida Therapeutics Inc. Company Information
  15. 8.3.2 Vida Therapeutics Inc. Business Overview
  16. 8.3.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product Portfolio
  18. 8.3.5 Vida Therapeutics Inc. Recent Developments
  19. 8.4 Carolus Therapeutics, Inc.
  20. 8.4.1 Carolus Therapeutics, Inc. Company Information
  21. 8.4.2 Carolus Therapeutics, Inc. Business Overview
  22. 8.4.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product Portfolio
  24. 8.4.5 Carolus Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Abdominal Aortic Aneurysm Drug Value Chain Analysis
  2. 9.1.1 Abdominal Aortic Aneurysm Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Abdominal Aortic Aneurysm Drug Sales Mode & Process
  6. 9.2 Abdominal Aortic Aneurysm Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Abdominal Aortic Aneurysm Drug Distributors
  9. 9.2.3 Abdominal Aortic Aneurysm Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst